| Symbol |
Name |
|
ABI1
|
abl-interactor 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACACA
|
acetyl-CoA carboxylase alpha
|
|
ADCY2
|
adenylate cyclase 2 (brain)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT1S1
|
AKT1 substrate 1 (proline-rich)
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
AMPH
|
amphiphysin
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AQP5
|
aquaporin 5
|
|
AR
|
androgen receptor
|
|
ARFGEF1
|
ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited)
|
|
ASIC1
|
acid sensing (proton gated) ion channel 1
|
|
ATIC
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP1A1
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
BACH1
|
BTB and CNC homology 1, basic leucine zipper transcription factor 1
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCR
|
breakpoint cluster region
|
|
BID
|
BH3 interacting domain death agonist
|
|
BLVRA
|
biliverdin reductase A
|
|
BRCA1
|
breast cancer 1, early onset
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CACNG2
|
calcium channel, voltage-dependent, gamma subunit 2
|
|
CAD
|
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
CAMK4
|
calcium/calmodulin-dependent protein kinase IV
|
|
CASC5
|
cancer susceptibility candidate 5
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CD163L1
|
CD163 molecule-like 1
|
|
CDC25C
|
cell division cycle 25C
|
|
CDCA8
|
cell division cycle associated 8
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CEBPE
|
CCAAT/enhancer binding protein (C/EBP), epsilon
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CLDN16
|
claudin 16
|
|
CLSPN
|
claspin
|
|
CNN3
|
calponin 3, acidic
|
|
CORO1A
|
coronin, actin binding protein, 1A
|
|
CPEB1
|
cytoplasmic polyadenylation element binding protein 1
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CRYAB
|
crystallin, alpha B
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNND2
|
catenin (cadherin-associated protein), delta 2
|
|
CUL3
|
cullin 3
|
|
DCK
|
deoxycytidine kinase
|
|
DGKA
|
diacylglycerol kinase, alpha 80kDa
|
|
DLG4
|
discs, large homolog 4 (Drosophila)
|
|
DPYSL2
|
dihydropyrimidinase-like 2
|
|
DSN1
|
DSN1, MIS12 kinetochore complex component
|
|
DSTN
|
destrin (actin depolymerizing factor)
|
|
DYNC1I2
|
dynein, cytoplasmic 1, intermediate chain 2
|
|
EEF1B2
|
eukaryotic translation elongation factor 1 beta 2
|
|
EEF1D
|
eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein)
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF3F
|
eukaryotic translation initiation factor 3, subunit F
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EP300
|
E1A binding protein p300
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOXG1
|
forkhead box G1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FXYD1
|
FXYD domain containing ion transport regulator 1
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GAP43
|
growth associated protein 43
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA4
|
GATA binding protein 4
|
|
GDPD5
|
glycerophosphodiester phosphodiesterase domain containing 5
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
H2AFX
|
H2A histone family, member X
|
|
H3F3A
|
H3 histone, family 3A
|
|
HCN4
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4
|
|
HDAC7
|
histone deacetylase 7
|
|
HIST1H1A
|
histone cluster 1, H1a
|
|
HIST1H3A
|
histone cluster 1, H3a
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HTT
|
huntingtin
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JUN
|
jun proto-oncogene
|
|
KCNA5
|
potassium channel, voltage gated shaker related subfamily A, member 5
|
|
KCND3
|
potassium channel, voltage gated Shal related subfamily D, member 3
|
|
KCNJ2
|
potassium channel, inwardly rectifying subfamily J, member 2
|
|
KCNJ4
|
potassium channel, inwardly rectifying subfamily J, member 4
|
|
KCNK3
|
potassium channel, two pore domain subfamily K, member 3
|
|
KCNN1
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 1
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KRT18
|
keratin 18, type I
|
|
KRT20
|
keratin 20, type I
|
|
KRT8
|
keratin 8, type II
|
|
LATS2
|
large tumor suppressor kinase 2
|
|
LIMK1
|
LIM domain kinase 1
|
|
LRP2
|
low density lipoprotein receptor-related protein 2
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP3K2
|
mitogen-activated protein kinase kinase kinase 2
|
|
MAP3K3
|
mitogen-activated protein kinase kinase kinase 3
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPT
|
microtubule-associated protein tau
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MIP
|
major intrinsic protein of lens fiber
|
|
MLXIPL
|
MLX interacting protein-like
|
|
MSN
|
moesin
|
|
MSX2
|
msh homeobox 2
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYBBP1A
|
MYB binding protein (P160) 1a
|
|
MYL12B
|
myosin, light chain 12B, regulatory
|
|
NBN
|
nibrin
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NKX3-1
|
NK3 homeobox 1
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NR1H4
|
nuclear receptor subfamily 1, group H, member 4
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NRIP1
|
nuclear receptor interacting protein 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
OCLN
|
occludin
|
|
OPRD1
|
opioid receptor, delta 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
ORC2
|
origin recognition complex, subunit 2
|
|
PCBP1
|
poly(rC) binding protein 1
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PFKFB2
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2
|
|
PFN1
|
profilin 1
|
|
PGAP3
|
post-GPI attachment to proteins 3
|
|
PLK1
|
polo-like kinase 1
|
|
PLN
|
phospholamban
|
|
PML
|
promyelocytic leukemia
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A
|
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B
|
|
PPP1R16B
|
protein phosphatase 1, regulatory subunit 16B
|
|
PRDX6
|
peroxiredoxin 6
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PRKD2
|
protein kinase D2
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTTG1IP
|
pituitary tumor-transforming 1 interacting protein
|
|
PXN
|
paxillin
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RANBP3
|
RAN binding protein 3
|
|
RANGAP1
|
Ran GTPase activating protein 1
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBBP8
|
retinoblastoma binding protein 8
|
|
RBX1
|
ring-box 1, E3 ubiquitin protein ligase
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
RGS5
|
regulator of G-protein signaling 5
|
|
RGS9
|
regulator of G-protein signaling 9
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RIPK2
|
receptor-interacting serine-threonine kinase 2
|
|
RPA2
|
replication protein A2, 32kDa
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
SCN2A
|
sodium channel, voltage gated, type II alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN8A
|
sodium channel, voltage gated, type VIII alpha subunit
|
|
SCNN1B
|
sodium channel, non voltage gated 1 beta subunit
|
|
SCNN1G
|
sodium channel, non voltage gated 1 gamma subunit
|
|
SF3B1
|
splicing factor 3b, subunit 1, 155kDa
|
|
SFPQ
|
splicing factor proline/glutamine-rich
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SIRT1
|
sirtuin 1
|
|
SLC12A1
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 1
|
|
SLC25A4
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMARCAL1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1
|
|
SMC1A
|
structural maintenance of chromosomes 1A
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPRED2
|
sprouty-related, EVH1 domain containing 2
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STX1A
|
syntaxin 1A (brain)
|
|
SYN1
|
synapsin I
|
|
TACC3
|
transforming, acidic coiled-coil containing protein 3
|
|
TBC1D4
|
TBC1 domain family, member 4
|
|
TCAP
|
titin-cap
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFEB
|
transcription factor EB
|
|
TJP2
|
tight junction protein 2
|
|
TNK2
|
tyrosine kinase, non-receptor, 2
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TOPBP1
|
topoisomerase (DNA) II binding protein 1
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TPD52
|
tumor protein D52
|
|
TPM1
|
tropomyosin 1 (alpha)
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TSC2
|
tuberous sclerosis 2
|
|
TTN
|
titin
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
USP4
|
ubiquitin specific peptidase 4 (proto-oncogene)
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VIM
|
vimentin
|
|
WASF2
|
WAS protein family, member 2
|
|
WASF3
|
WAS protein family, member 3
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|